RxDoctor Payments Data

Sacha Degraffenreid Yates

Family · Joplin, MONPI 1275088437

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,336, more than ten times the $107 reported in 2021. Among family clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,685in general payments, 2019–2025

Across 307 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • UCB, Inc.$682
  • GSK$541
  • Pfizer$442
  • Novartis$414
  • AstraZeneca$390
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$5,59298%
  • Education$932%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,685 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Other family in Joplin

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →